Rakesh 2015.

Study characteristics
Methods	Study design: parallel RCT Number of centers/setting: not reported Country: India Dates of the study: not reported
Participants	Total number of participantsrandomized: 120 tamsulosin group: not reported no adjuvant therapy group: not reported DJ stenting ≥ 1 week before ESWL group: not reported Age: not reported Sex (M/F): not reported Stone location: not reported Stone size: not reported Inclusion criteria: inclusion criteria for ESWL Exclusion criteria: exclusion criteria for ESWL
Interventions	Treatment group: tamsulosin for max 30 days standard care: not reported Control group: no adjuvant therapy SWL: not reported
Outcomes	Stone fragmentation, stone clearance, postprocedure analgesic requirement and final success of ESWL procedure How measured: not reported Time point measured: not reported Subgroups: stone location (lower, non‐lower calyx), stone size, stone density (CT Hounsfield units)
Funding sources	Not reported
Declarations of interest	Not reported
Notes	Language of publication: English Type of publication: abstract only Date of contact attempt with study authors: none Contact status: N/A
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Comment: method of sequence generation not described.
Allocation concealment (selection bias)	Unclear risk	Comment: unclear whether allocation was concealed.
Blinding of participants and personnel (performance bias) All outcomes	High risk	Comment: no mention of placebo; participants likely not blinded.
Blinding of outcome assessment (detection bias) Investigator assessed; susceptible (stone clearance, time to stone clearance)	High risk	Comment: investigators likely not blinded.
Blinding of outcome assessment (detection bias) Investigator assessed; susceptible (major adverse events)	High risk	Comment: investigators likely not blinded.
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	Comment: unable to assess what proportion of randomized participants were included in outcome analyses.
Selective reporting (reporting bias)	Unclear risk	Comment: no protocol available.
Other bias (additional SWL sessions)	Unclear risk	Comment: unclear whether > 1 SWL session was administered.